 Imaging Warburg effect, principal sole cause enhanced glucose metabolism tumors, PET (18)F-FDG become mainstay imaging evaluation several cancers. Despite seemingly prevalent notion (18)F-FDG PET may useful prostate cancer, relatively limited evidence suggests imaging modality useful evaluation extent metastatic disease assessment therapy response prognosis men castration-resistant prostate cancer. Incidental high focal (18)F-FDG uptake prostate gland, although generally rare, may also indicate occult prostate cancer may need scrutinized. general, (18)F-FDG PET useful initial staging limited utility clinical setting biochemical failure prior definitive therapy primary cancer. Although experience needed, appears imaging cellular proliferation PET 3'-deoxy-3'-(18)F-fluorothymidine 2'-(18)F-fluoro-5-methyl-1-beta-d-arabinofuranosyluracil may also allow targeted biopsy localization focal therapy aggressive prostate tumors well assessment therapy response various standard novel treatment regimens patients metastatic disease.